Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors.
Artificial Intelligence; Big Data; Breast Neoplasms; Cancer Survivors; Female; Humans; Multicenter Studies as Topic; Prospective Studies; Quality of Life; Retrospective Studies; Survivorship; Conversational agent; Digital intervention; Health application; Single-case experimental prospective study; Well-being
Abstract :
[en] BACKGROUND: It is encouraging to see a substantial increase in individuals surviving cancer. Even more so since most of them will have a positive effect on society by returning to work. However, many cancer survivors have unmet needs, especially when it comes to improving their quality of life (QoL). Only few survivors are able to meet all of the recommendations regarding well-being and there is a body of evidence that cancer survivors' needs often remain neglected from health policy and national cancer control plans. This increases the impact of inequalities in cancer care and adds a dangerous component to it. The inequalities affect the individual survivor, their career, along with their relatives and society as a whole. The current study will evaluate the impact of the use of big data analytics and artificial intelligence on the self-efficacy of participants following intervention supported by digital tools. The secondary endpoints include evaluation of the impact of patient trajectories (from retrospective data) and patient gathered health data on prediction and improved intervention against possible secondary disease or negative outcomes (e.g. late toxicities, fatal events). METHODS/DESIGN: The study is designed as a single-case experimental prospective study where each individual serves as its own control group with basal measurements obtained at the recruitment and subsequent measurements performed every 6 months during follow ups. The measurement will involve CASE-cancer, Patient Activation Measure and System Usability Scale. The study will involve 160 survivors (80 survivors of Breast Cancer and 80 survivors of Colorectal Cancer) from four countries, Belgium, Latvia, Slovenia, and Spain. The intervention will be implemented via a digital tool (mHealthApplication), collecting objective biomarkers (vital signs) and subjective biomarkers (PROs) with the support of a (embodied) conversational agent. Additionally, the Clinical Decision Support system (CDSS), including visualization of cohorts and trajectories will enable oncologists to personalize treatment for an efficient care plan and follow-up management. DISCUSSION: We expect that cancer survivors will significantly increase their self-efficacy following the personalized intervention supported by the m-HealthApplication compared to control measurements at recruitment. We expect to observe improvement in healthy habits, disease self-management and self-perceived QoL. Trial registration ISRCTN97617326. https://doi.org/10.1186/ISRCTN97617326 . Original Registration Date: 26/03/2021.
Disciplines :
Orthopedics, rehabilitation & sports medicine
Author, co-author :
Mlakar, Izidor
Lin, Simon
Aleksandraviča, Ilona
Arcimoviča, Krista
Eglītis, Jānis
Leja, Mārcis
Salgado Barreira, Ángel
Gómez, Jesús G.
Salgado, Mercedes
Mata, Jesús G.
Batorek, Doroteja
Horvat, Matej
Molan, Maja
Ravnik, Maja
Kaux, Jean-François ; Université de Liège - ULiège > Département des sciences de la motricité > Médecine physique, réadaptation et traumatologie du sport
BLERET, Valerie ; Centre Hospitalier Universitaire de Liège - CHU > Département de gynécologie-obstétrique > Service de sénologie
LOLY, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive
Maquet, Didier ; Université de Liège - ULiège > Département des sciences de la motricité > Département des sciences de la motricité
Patients-centered SurvivorShIp care plan after Cancer treatments based on Big Data and Artificial Intelligence technologies (PERSIST): a multicenter study protocol to evaluate efficacy of digital tools supporting cancer survivors.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. DOI: 10.3322/caac.21492
Eurofound. Sixth European working conditions survey—overview report. Luxembourg: Publications Office of the European Union; 2016.
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.
Gatta G, Mallone S, van der Zwan JM, Trama A, Siesling S, Capocaccia R, et al. Cancer prevalence estimates in Europe at the beginning of 2000. Ann Oncol. 2013;24(6):1660–6.
Micheli A, Mugno E, Krogh V, Quinn MJ, Coleman M, Hakulinen T, et al. Cancer prevalence in European registry areas. Ann Oncol. 2002;13(6):840–65.
De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE—5-a population-based study. Lancet Oncol. 2014;15(1):23–34. 10.1016/S1470-2045(13)70546-16. DOI: 10.1016/S1470-2045(13)70546-16
Armes J, Crowe M, Colbourne L, Morgan H, Murrells T, Oakley C, Palmer N, Ream E, Young A, Richardson A. Patients’ supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol. 2009;27:6172–9. 10.1200/JCO.2009.22.5151. DOI: 10.1200/JCO.2009.22.5151
Cured—But at what cost? Long term consequences of cancer and its treatment. Report. Available online at https://kingsfund.blogs.com/health_management/2013/07/cured-but-at-what-cost-long-term-consequences-of-cancer-and-its-treatment.html.
Henry-Amar M, Busson R. Does persistent fatigue in survivors relate to cancer? Lancet Oncol. 2016;17:1351–2. 10.1016/S1470-2045(16)30156-5. DOI: 10.1016/S1470-2045(16)30156-5
Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21:571–87. 10.1002/pon.2070. DOI: 10.1002/pon.2070
Zeltzer K, Lu Q, Leisenring W, Tsao JCI, Recklitis C, Armstrong G, Mertens AC, Robison LL, Ness KK. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the childhood cancer survivor study. Cancer Epidemiol Biomark Prev. 2008;17:435–46. 10.1158/1055-9965.EPI-07-2541. DOI: 10.1158/1055-9965.EPI-07-2541
Economist Intelligence Unit. Cancer in the Workplace. London: Economist Intelligence Unit; 2017.
Courneya KS. Physical activity and cancer survivorship: a simple framework for a complex field. Exerc Sport Sci Rev. 2014;42:102–9. 10.1249/JES.0000000000000011. DOI: 10.1249/JES.0000000000000011
Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ. Cancer cachexia: beyond weight loss. J Oncol Pract. 2016;12(11):1163–71.
Blanchard CM, Courneya KS, Stein K, American Cancer Society’s SCS-II. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American cancer society’s SCS-II. J Clin Oncol. 2008;26:2198–204. 10.1200/JCO.2007.14.6217. DOI: 10.1200/JCO.2007.14.6217
De Lorenzo F, Apostolidis K, Florindi F, Makaroff LE. Improving European policy to support cancer survivors. J Cancer Policy. 2018;15:72–5.
Aapro M, Bossi P, Dasari A, Fallowfield L, Gascón P, Geller M, Jordan K, Kim J, Martin K, Porzig S. Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer. 2020;28:1–24.
Hong YA, Hossain MM, Chou WYS. Digital interventions to facilitate patient-provider communication in cancer care: a systematic review. Psychooncology. 2020;29(4):591–603.
Lozano-Lozano M, Cantarero-Villanueva I, Martin-Martin L, Galiano-Castillo N, Sanchez MJ, Fernández-Lao C, Postigo-Martin P, Arroyo-Morales M. A mobile system to improve quality of life via energy balance in breast cancer survivors (BENECA mHealth): prospective test-retest quasiexperimental feasibility study. JMIR mHealth uHealth. 2019;7(6):e14136.
Nordan L, Blanchfield L, Niazi S, Sattar J, Coakes CE, Uitti R, Vizzini M, Naessens JM, Spaulding A. Implementing electronic patient-reported outcomes measurements: challenges and success factors. BMJ Qual Saf. 2018;27(10):852–6.
Chang EM, Gillespie EF, Shaverdian N. Truthfulness in patient-reported outcomes: factors affecting patients’ responses and impact on data quality. Patient Relat Outcome Meas. 2019;10:171.
Project PERSIST. Last visited March 2021. https://projectpersist.com/.
Wolf MS, Chang CH, Davis T, Makoul G. Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer). Patient Educ Couns. 2005;57(3):333–41.
Tsai CL, Chaichanasakul A, Zhao R, Flores LY, Lopez SJ. Development and validation of the strengths self-efficacy scale (SSES). J Career Assess. 2014;22(2):221–32.
Ziner KW, Sledge Jr GW, Bell CJ, Johns S, Miller KD, Champion VL. Predicting fear of breast cancer recurrence and self-efficacy in survivors by age at diagnosis. In: Oncology nursing forum, vol 39, No. 3. NIH Public Access; 2012. p. 287.
Thewes B, Bell ML, Butow P. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors. Psychooncology. 2013;22(9):2059–63.
Palas JMC, Hyland KA, Nelson AM, Small BJ, Jim HS, Jacobsen PB. An examination of the relationship of patient modifiable and non-modifiable characteristics with fear of cancer recurrence among colorectal cancer survivors. Support Care Cancer. 2021;29(2):869–76.
O’Malley D, Dewan AA, Ohman-Strickland PA, Gundersen DA, Miller SM, Hudson SV. Determinants of patient activation in a community sample of breast and prostate cancer survivors. Psychooncology. 2018;27(1):132–40.
van der Hout A, Holtmaat K, Jansen F, Lissenberg-Witte BI, van Uden-Kraan CF, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. The eHealth self-management application ‘Oncokompas’ that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta Oncol. 2020;60:1–9.
Hibbard JH, Mahoney E, Sonet E. Does patient activation level affect the cancer patient journey? Patient Educ Couns. 2017;100(7):1276–9.
Lewis JR. The system usability scale: past, present, and future. Int J Hum Comput Interact. 2018;34(7):577–90.
Laugwitz B, Held T, Schrepp M. Construction and evaluation of a user experience questionnaire. In: Holzinger A (ed.) USAB 2008, LNCS 5298; 2008, pp. 63–76.
Zhao Y, Ni Q, Zhou R. What factors influence the mobile health service adoption? A meta-analysis and the moderating role of age. Int J Inf Manag. 2018;43:342–50.
HealthIT, Office of the National Coordinator for Health Information Technology (ONC), US Department of Health Human Services. What are patient-generated health data? Accessed October 15, 2019. https://healthit.gov/topic/otherhot-topics/what-are-patient-generated-health-data
Jim HS, Hoogland AI, Brownstein NC, Barata A, Dicker AP, Knoop H, Gonzalez BD, Perkins R, Rollison D, Gilbert SM, Nanda R, Berglund A, Mitchell R, Johnstone PA. Innovations in research and clinical care using patient-generated health data. CA Cancer J Clin. 2020;70(3):182–99.
Rathod KS, Wragg A. Do patient-reported outcome measures speak for all patient subgroups: is everyone included? Eur Heart J - Qual Care Clin Outcomes. 2018;4(2):79–80. https://doi.org/10.1093/ehjqcco/qcy004.
NCCN Guidelines Version 3.2017: Survivorship, last visited 25 Apr 2021. https://oncolife.com.ua/doc/nccn/Survivorship.pdf.
Conijn JM, Emons WH, Page BF, Sijtsma K, Van der Does W, Carlier IV, Giltay EJ. Response inconsistency of patient-reported symptoms as a predictor of discrepancy between patient and clinician-reported depression severity. Assessment. 2018;25(7):917–28.
Jones SM, Du Y, Bell-Brown A, Bolt K, Unger JM. Feasibility and validity of asking patients to define individual levels of meaningful change on patient-reported outcomes. J Patient-Centered Res Rev. 2020;7(3):239.
Schneider S, May M, Stone AA. Careless responding in internet-based quality of life assessments. Qual Life Res. 2018;27(4):1077–88.
Maniaci MR, Rogge RD. Caring about carelessness: participant inattention and its effects on research. J Res Pers. 2014;48:61–83.
Krasny-Pacini A, Evans J. Single-case experimental designs to assess intervention effectiveness in rehabilitation: a practical guide. Ann Phys Rehabil Med. 2018;61(3):164–79.
Dallery J, Cassidy RN, Raiff BR. Single-case experimental designs to evaluate novel technology-based health interventions. J Med Internet Res. 2013;15(2):e22.
Rojc M, Mlakar I, Kačič Z. The TTS-driven affective embodied conversational agent EVA, based on a novel conversational-behavior generation algorithm. Eng Appl Artif Intell. 2017;57:80–104.
Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012;28(1):44–51.
Jones JM, Olson K, Catton P, Catton CN, Fleshner NE, Krzyzanowska MK, McCready DR, Wong RK, Jiang H, Howell D. Cancer-related fatigue and associated disability in post-treatment cancer survivors. J Cancer Surviv. 2016;10(1):51–61.
Kulnik ST, Nikoletou D. WHODAS 2.0 in community rehabilitation: a qualitative investigation into the validity of a generic patient-reported measure of disability. Disabil Rehabil. 2014;36(2):146–54.
Lee HH, Shin EK, Shin HI, Yang EJ. Is WHODAS 2.0 useful for colorectal cancer survivors? Ann Rehabil Med. 2017;41(4):667.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: a user’s portfolio causal and control beliefs. Windsor: NFER-NELON; 1995. p. 35–7.
Feldstain A, Lebel S, Chasen MR. An interdisciplinary palliative rehabilitation intervention bolstering general self-efficacy to attenuate symptoms of depression in patients living with advanced cancer. Support Care Cancer. 2016;24(1):109–17.
Denlinger CS, Sanft T, Moslehi JJ, Overholser L, Armenian S, Baker KS, Broderick G, Demark-Wahnefried W, Friedman DL, Goldman M, Henry NL, Hill-Kayser C, Hudson M, Khakpour N, Koura D, McDonough AL, Melisko M, Mooney K, Moore HCF, Moryl N, O’Connor T, Paskett ED, Patel C, Peterson L, Pirl W, Alma Rodriguez M, Ruddy KJ, Shockney L, Smith S, Syrjala KL, Tevaarwerk A, Zee P, McMillian NR, Freedman-Cass DA. NCCN guidelines insights: survivorship, version 2.2020: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw. 2020;18(8):1016–23.
Scott NW, Fayers P, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA, EORTC Quality of Life Group. EORTC QLQ-C30 Reference Values, EORTC Quality of Life Group Publications. 2008; http://groups.eortc.be/qol/manuals.
Ky B, Vejpongsa P, Yeh ET, Force T, Moslehi JJ. Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res. 2013;113(6):754–64.
Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Ung OA, Dylke ES, French JR, Yee J, Koelmeyer L, Gaitatzis K. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast. 2016;28:29–36.
McLaughlin SA, Stout NL, Schaverien MV. Avoiding the swell: advances in lymphedema prevention, detection, and management. Am Soc Clin Oncol Educ Book. 2020;40:1–10.
Denlinger CS, Carlson RW, Are M, Baker KS, Davis E, Edge SB, Friedman DL, Goldman M, Jones L, King A, Kvale E, Langbaum TS, Ligibel JA, McCabe MS, McVary KT, Melisko M, Montoya JG, Mooney K, Morgan MA, O’Connor T, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D. Survivorship: introduction and definition. J Natl Compr Canc Netw. 2014;12(1):34–45.
Hershman DL, Lacchetti C, Dworkin RH, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32:1941–67.
Paice JA, Portenoy R, Lacchetti C, et al. management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016;34:3325–45.
Ware LJ, Epps CD, Herr K, Packard A. Evaluation of the revised faces pain scale, verbal descriptor scale, numeric rating scale, and Iowa pain thermometer in older minority adults. Pain Manag Nurs. 2006;7(3):117–25.
Chandwani KD, Heckler CE, Mohile SG, Mustian KM, Janelsins M, Peppone LJ, Bushunow P, Flynn PJ, Morrow GR. Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer. Explore. 2014;10(4):241–7.
Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol. 1998;16(2):501–14.
Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR. Body image and sexual problems in young women with breast cancer. Psycho-Oncol J Psychol Soc Behav Dimens Cancer. 2006;15(7):579–94.
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszweksi KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A, Bleiker E, Bliem B, Chie W, Creutzberg C, Deville V, Duhoux F, Eilf K, Hartup S, Koller M, Nagele E, Nicolatou-Galitis O, Oberguggenberger A, Schmalz C, Winters Z. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Ann Oncol. 2020;31(2):283–8.
Butt Z, Wagner LI, Beaumont JL, Paice JA, Peterman AH, Shevrin D, Von Roenn JH, Carro G, Straus JL, Muir JC, Cella D. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manag. 2008;35(1):20–30.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.
Zhong Q, Gelaye B, Rondon M, Sánchez SE, García PJ, Sánchez E, Barrios YV, Simon GE, Henderson DC, Cripe SM, Williams MA. Comparative performance of patient health questionnaire-9 and Edinburgh Postnatal Depression Scale for screening antepartum depression. J Affect Disord. 2014;162:1–7.
Li C, Friedman B, Conwell Y, Fiscella K. Validity of the Patient Health Questionnaire 2 (PHQ-2) in identifying major depression in older people. J Am Geriatr Soc. 2007;55(4):596–602.
Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509–15.
Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens MR, Vandenberghe J, Vandenbulcke M, Sunaert S. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol. 2012;30(3):274–81.
Deprez S, Billiet T, Sunaert S, Leemans A. Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review. Brain Imaging Behav. 2013;7(4):409–35.
Van Dyk K, Hunter AM, Ercoli L, Petersen L, Leuchter AF, Ganz PA. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography. Breast Cancer Res Treat. 2017;166(1):157–66.
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, Bandera EV, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):242–74.
Fong DY, Ho JW, Hui BP, Lee AM, Macfarlane DJ, Leung SS, Cerin E, Chan WYY, Leung IPF, Lam SHS, Taylor AJ, Cheng KK. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344:e70.
Bull FC, Maslin TS, Armstrong T. Global Physical Activity Questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009;6(6):790–804.
Pope Z, Lee JE, Zeng N, Lee HY, Gao Z. Feasibility of smartphone application and social media intervention on breast cancer survivors’ health outcomes. Transl Behav Med. 2019;9(1):11–22.
Quintiliani LM, Mann DM, Puputti M, Quinn E, Bowen DJ. Pilot and feasibility test of a mobile health-supported behavioral counseling intervention for weight management among breast cancer survivors. JMIR Cancer. 2016;2(1):e5305.
Albreht T, Amati C, Angelastro A, et al. European guide on quality improvement in comprehensive cancer Control. In: Albreht T, Kiasuwa R, Van den Bulche M (eds.). Integrated cancer Control: the case for comprehensive cancer care networks (CCCN). Ljubljana, Slovenia, National Institute of Public Health, Brussels, Belgium; 2017, p. 77–103.
